Article
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers.
BMC cancer - 6 Aug 2007
Friedenson Bernard
Abstract excerpt
BACKGROUND: The present study was designed to test the hypothesis that inactivation of virtually any component within the pathway containing the BRCA1 and BRCA2 proteins would increase the risks for lymphomas and leukemias. In people who do not have BRCA1 or BRCA2 gene mutations, the encoded proteins prevent breast/ovarian cancer. However BRCA1 and BRCA2 proteins have multiple functions including participating in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
